Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01022307 · ClinicalTrials.gov registry record
Quantitative Automated Lesion Detection of Traumatic Brain Injury
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 212
- Enrollment target
NCT01022307: Completed study, sponsored by VA Office of Research and Development.
NCT01022307 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 212 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01022307 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 212 participants
- Enrollment target
Study Summary
The investigators propose to develop quantitative automated lesion detection (QALD) procedures to identify brain damage following traumatic brain injury more accurately than is possible with a normal magnetic resonance imaging (MRI) scans. These procedures require about 1 hour of imaging in an MRI scanner. Subjects will also undergo about 2 hours of cognitive tests. The investigators will compare the results of the cognitive tests with those from MRI scanning to determine what brain regions are responsible for superior performance and for performance decrements.
Primary Outcome
z-score based on response time, regressed for age and computer use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2009-05 |
| Est. Completion | 2014-10 |
What the finished NCT01022307 record still lists
NCT01022307 is an observational study that tracks outcomes without assigning an intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01022307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01022307 about?
NCT01022307 is a clinical study titled "Quantitative Automated Lesion Detection of Traumatic Brain Injury". The investigators propose to develop quantitative automated lesion detection (QALD) procedures to identify brain damage following traumatic brain injury more accurately than is possible with a normal magnetic resonance imaging (MRI) scans. These procedures require about 1 hour of imaging in an MRI s...
What is the current status of trial NCT01022307?
This trial is currently completed. The enrollment target is 212 participants. The study started on 2009-05. Estimated completion is 2014-10.
Who is sponsoring clinical trial NCT01022307?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
- NCT06456593 · 212 participants · Phase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia